These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33929600)

  • 1. Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma.
    Yoo J; Kim JH; Bae JS; Kang HJ
    Abdom Radiol (NY); 2021 Sep; 46(9):4159-4169. PubMed ID: 33929600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
    Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
    Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma.
    Yamada M; Mizuno T; Yamaguchi J; Yokoyama Y; Igami T; Onoe S; Watanabe N; Uehara K; Matsuo K; Ebata T
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):768-777. PubMed ID: 34717042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Noninvasive MRI-Based Signature for Preoperative Prediction of Early Recurrence in Perihilar Cholangiocarcinoma.
    Zhao J; Zhang W; Zhu YY; Zheng HY; Xu L; Zhang J; Liu SY; Li FY; Song B
    J Magn Reson Imaging; 2022 Mar; 55(3):787-802. PubMed ID: 34296802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.
    Bartsch F; Hahn F; Müller L; Baumgart J; Hoppe-Lotichius M; Kloeckner R; Lang H
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):262-270. PubMed ID: 32861577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
    van Keulen AM; Buettner S; Erdmann JI; Pratschke J; Ratti F; Jarnagin WR; Schnitzbauer AA; Lang H; Ruzzenente A; Nadalin S; Cescon M; Topal B; Olthof PB; Groot Koerkamp B;
    Br J Surg; 2023 Apr; 110(5):599-605. PubMed ID: 36918735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: A pilot study.
    Zhao J; Zhang W; Fan CL; Zhang J; Yuan F; Liu SY; Li FY; Song B
    Eur J Radiol; 2021 May; 138():109631. PubMed ID: 33711571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
    Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hilar cholangiocarcinoma: Value of high-resolution enhanced magnetic resonance imaging for preoperative evaluation.
    Xin Y; Liu Q; Zhang J; Lu J; Song X; Zhan H; Chen X; Cao Z; Li Y; Huang Z
    J Cancer Res Ther; 2020; 16(7):1634-1640. PubMed ID: 33565510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.